In a move to expand its portfolio beyond antibiotics, Paratek Pharmaceuticals has bought out Optinose and its chronic ...

Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, announces the approval of KLOXXADO ® (naloxone HCl) Nasal Spray 8 mg, by Health Canada for the treatment of ...

Up to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...

Payment options are available based on insurance coverage. The FDA has approved neffy 1 mg epinephrine nasal spray for treating anaphylaxis and other type 1 allergic reactions in children aged 4 ...

Ketamine has gained attention for its depression treatment potential, particularly with the FDA approval of Spravato nasal spray. Market growth is driven by rising mental health issues ...

Ketamine has gained attention for its depression treatment potential, particularly with the FDA approval of Spravato nasal spray.

Ketamine has gained attention for its depression treatment potential, particularly with the FDA approval of Spravato nasal spray.

MDMA, although not providing specific usage data, remains popular, especially in research for PTSD treatment. Ketamine has gained attention for its depression treatment potential, particularly with ...

Ketamine has gained attention for its depression treatment potential, particularly with the FDA approval of Spravato nasal spray. Market growth is driven by rising mental health issues ...

CINCINNATI (WKRC) - The Food and Drug Administration issued a recall for certain nasal spray that tested positive for a bacterial contaminate that could lead to "potentially life-threatening ...